Safdar A*, Decker W, Li S, Shpall E, Zabriskie R, Machado A, Gilbert B. Dendritic cell vaccination generates protective responses against influenzavirus infection: a model of effective vaccination for immunosuppressed cancer and hematopoietic stem cell transplant patients. The 13th Annual Conference on Vaccine Research, National Foundation for Infectious Diseases, National Institutes of Health, Bethesda, Maryland April 26th 2010 ORAL PRESENTATION

/in /by

Decker W, Li S, Zabriskie R, Machado A, Gilbert B, Shpall EJ, Safdar A* Dendritic cell vaccination generates protective responses against influenza virus infection: a model explored for effective vaccination of immunosuppressed cancer and stem cell transplant patients. Abstract # 77. The 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria April 10-13, 2010 ORAL PRESENTATION

/in /by

Ahmed SI, Rodriguez GH, Al-Akhrass F, Rallapalli GV, Safdar A. Infectious complications in patients treated with dasatinib. Abstract # 442. The 47th Annual Meeting of Infectious Diseases Society of America. October 29–November 1st, 2009 Philadelphia, PA

/in /by

Rodriguez GH, Ejaz S, Ahmed S, Safdar A. Multiple granulocyte transfusions for the treatment of severe opportunistic infections in cancer patients – 2004–2007. Abstract # 443. The 47th Annual Meeting of Infectious Diseases Society of America. October 29–November 1st, 2009 Philadelphia, PA

/in /by

Rodriguez G, Rallapalli V, Safdar A. Feasibility of aerosolized amphotericin B lipid complex therapy in cancer patients with pulmonary fungal infections. Abstract # 415. The 47th Annual Meeting of Infectious Diseases Society of America, October 29–November 1st, 2009 Philadelphia, PA

/in /by

Decker W, Shpall E, Safdar A*. An umbilical cord blood model of dendritic cell vaccine demonstrates the ex vivo generation of de novo strain-specific T-lymphocyte responses against influenza A H1N1, H5N1 & H7N7. Abstract # G1-889/362. The 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15th, 2009 San Francisco, CA

/in /by

Raad I, Ramos E, Hachem R, Jiang Y, Torres H, Al-Akhrass F, Kontoyiannis D, Safdar A. Are white blood cell transfusions useful in the salvage treatment of invasive aspergillosis in neutropenic hematologic malignancy patients? The 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15th, 2009 San Francisco, CA

/in /by

Decker W, Shpall E, Safdar A*. An umbilical cordblood model of dendritic cell vaccination demonstrates the ex vivo generation of de novo strain-specific T-lymphocyte responses. Abstract # O175. The 19th European Congress of Clinical Microbiology and Infectious Diseases. May 16–19th, 2009 Helsinki, Finland ORAL PRESENTATION

/in /by

Ahmed S, Rodriguez G, Ejaz S, Al Akhrass F, Safdar A*. Infectious complications in cancer patients treated with dasatinib (BMS-354825). Abstract # P176. The 19th European Congress of Clinical Microbiology and Infectious Diseases. May 16–19th, 2009 Helsinki, Finland.

/in /by

Safdar A, Georgescu G, Rodriguez G, Champlin R. Granulocyte macrophage colony stimulating factor in stem cell transplant recipients: response to immuneenhancement in early versus late serious post-transplant infections. Abstract # 2203. The 2008 Annual Meeting of the American Society of Hematology. Blood (ASH Annual Meeting Abstracts), Nov 2008;112:4373.

/in /by